Human follicular fluid protease and antiprotease activities: a suggested correlation with ability of oocytes to undergo in vitro fertilization.
Plasminogen activator activity was determined in human follicular fluids (FFs) obtained during in vitro fertilization procedures. The fibrinolytic activity of plasminogen activator was significantly higher in fluids from follicles that contained oocytes that were later found to fertilize in vitro (group F) as compared with fluids from follicles that contained oocytes that failed to fertilize (NF). To assess whether this difference in overt plasminogen activator activity reflects differences in conversion of an inactive, latent plasminogen activator to the active enzyme, the ability of exogenous trypsin to enhance plasminogen activation was measured. The plasminogen-dependent hydrolysis of the chromogenic substrate S-2444 in presence of trasylol (Bayer, Leverkusen, Germany) was taken as a measure of plasminogen activator activity in these experiments. No activity was found in untreated FFs, while exposure to trypsin resulted in emergence of marked plasminogen activator activity. In addition, FFs exhibited trasylol-sensitive chromogenic activity indicative of serine-protease activity. Both the plasminogen activator and serine-protease levels after tryptic activation were significantly higher in NF than in F samples. Thus, while F samples have most of their plasminogen activator in an active form, NF samples have most of their plasminogen activator in a latent, trypsin-activatable form. Follicular fluids also contain inhibitory activities toward plasmin and trypsin. The inhibition of these enzymes correlates positively with the latency of plasminogen activator. These results suggest a direct relationship between the ability of oocytes to fertilize and the overt to latent plasminogen activator activity ratios in the FFs.
Milwidsky
A
A
Department of Obstetrics and Gynecology, Hadassah University Hospital, Mount Scopus, Jerusalem, Israel.
Kaneti
H
H
Finci
Z
Z
Laufer
N
N
Tsafriri
A
A
Mayer
M
M
D010450:Endopeptidases / Q000378:metabolism*; D005260:Female; D005306:Fertilization; D005307:Fertilization in Vitro; D005341:Fibrinolysin / Q000037:antagonists & inhibitors; D006801:Humans; D009865:Oocytes / Q000502:physiology*; D006080:Ovarian Follicle / Q000201:enzymology* / Q000378:metabolism; D010960:Plasminogen Activators / Q000378:metabolism; D011247:Pregnancy; D011480:Protease Inhibitors / Q000378:metabolism*; D014361:Trypsin Inhibitors / Q000378:metabolism
D011480:Protease Inhibitors; D014361:Trypsin Inhibitors; D010450:Endopeptidases; D010960:Plasminogen Activators; D005341:Fibrinolysin